Jérémie Botton

发表

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

M. Bertrand, M. Zureik, R. Dray-Spira, 2022, Nature Communications.

No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease

M. Zureik, R. Dray-Spira, O. Saint-Lary, 2022, Research and Practice in Thrombosis and Haemostasis.

Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster

M. Bertrand, M. Zureik, R. Dray-Spira, 2023, The New England journal of medicine.

Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France

M. Bertrand, M. Zureik, P. Farrington, 2022, Annals of Internal Medicine.

Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case–Control Study Based on the French National Health Data System

M. Zureik, J. Drouin, Marie-Joëlle Jabagi, 2023, Open forum infectious diseases.

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France

M. Bertrand, M. Zureik, R. Dray-Spira, 2022, The Lancet Regional Health - Europe.

Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines

M. Zureik, J. Drouin, Marie-Joëlle Jabagi, 2023, Neurology.